Concord Wealth Partners
BSX icon

Concord Wealth Partners’s Boston Scientific BSX Stock Holding History

Concord Wealth Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$16K Buy
367
+100
+37% +$4.63K ﹤0.01% 489
2026
Q2 		$11.4K Buy
+267
New +$14.5K ﹤0.01% 554
2026
Q1 		– Sell
-3,907
Closed -$373K – 272
2025
Q4 		$373K Buy
3,907
+272
+7% +$26.7K 0.05% 155
2025
Q3 		$355K Buy
3,635
+3,368
+1,261% +$349K 0.05% 161
2025
Q2 		$28.7K Hold
267
– – ﹤0.01% 414
2025
Q1 		$26.9K Sell
267
-297
-53% -$29.9K ﹤0.01% 399
2024
Q4 		$50.4K Hold
564
– – 0.01% 327
2024
Q3 		$47.3K Hold
564
– – 0.01% 345
2024
Q2 		$43.4K Sell
564
-57
-9% -$4.17K 0.01% 329
2024
Q1 		$42.5K Hold
621
– – 0.01% 378
2023
Q4 		$35.9K Sell
621
-280
-31% -$14.9K 0.01% 401
2023
Q3 		$47.6K Buy
901
+61
+7% +$3.2K 0.01% 386
2023
Q2 		$45.4K Hold
840
– – 0.01% 380
2023
Q1 		$42K Buy
840
+314
+60% +$14.8K 0.01% 371
2022
Q4 		$24.3K Buy
+526
New +$22.8K 0.01% 495
2022
Q3 		– Sell
-574
Closed -$21K – 285
2022
Q2 		$21K Sell
574
-1,563
-73% -$63.6K 0.01% 532
2022
Q1 		$95K Sell
2,137
-74
-3% -$3.21K 0.02% 308
2021
Q4 		$94K Buy
2,211
+1,578
+249% +$66.3K 0.02% 318
2021
Q3 		$27K Sell
633
-1,023
-62% -$45.3K 0.01% 324
2021
Q2 		$71K Buy
1,656
+259
+19% +$10.9K 0.02% 291
2021
Q1 		$54K Buy
1,397
+1,368
+4,717% +$51.8K 0.02% 324
2020
Q4 		$1K Buy
+29
New +$1.04K ﹤0.01% 601

Other funds holding BSX

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return

Concord Wealth Partners's BSX Position: Q3 2026 in Review

Concord Wealth Partners increased its Boston Scientific (BSX) stake by 37% in Q3 2026, buying an estimated $4.63K and bringing the position to 367 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #489.

Concord Wealth Partners first reported a position in BSX in Q4 2020 and has held it in 22 quarters since. The position peaked at $373K in Q4 2025. 1,274 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Concord Wealth Partners held 367 shares of Boston Scientific worth $16K as of Q3 2026.
  • Concord Wealth Partners bought 100 Boston Scientific shares in Q3 2026, an estimated $4.63K.
  • Boston Scientific made up ﹤0.01% of Concord Wealth Partners's portfolio in Q3 2026, its #489 holding.
  • Concord Wealth Partners first reported a position in Boston Scientific in Q4 2020 and has held it in 22 quarters since.
  • Concord Wealth Partners's Boston Scientific position peaked at $373K in Q4 2025.
  • 1,274 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Concord Wealth Partners's 13F filing for Q3 2026, filed 2 Nov 2026.